Patent details

Basic Information

Publication number:

LUC00050

Type:

SPC

SPC Type:

Medical

Basic Patent Number:

EP077773802

Legal Status:

Inactive

Application number:

LUC00050

First applicant's nationality:

Procedural language:

French

Marketing Authorization

Marketing Authorization Number:

EU/1/17/1196

Marketing Authorization Type:

Marketing Authorization Date:

27/06/2017

Marketing Authorization Status:

Accepted

Marketing Authorization Country:

Luxembourg (LU)

Dates

Filing date:

22/11/2017

First Marketing Authorization date:

27/06/2017

Grant date:

23/01/2018

Activation date:

Publication date:

22/11/2017

Lapsed date:

Expiration date:

Renunciation date:

Revocation date:

Annulment date:

Basic SPC Expiration:

01/06/2032

SPC Extension Expiration:

01/06/2032

Rejection date:

Withdrawal date:

Owner

From:

22/11/2017

 

 

Name:

REGENERON PHARMACEUTICALS, INC.

Address:

777 Old Saw Mill River Road, Tarrytown, NY 10591, United States (US)

Agent

Name:

OFFICE FREYLINGER S.A.

From:

22/11/2017

Address:

PO Box 48, 8001, STRASSEN, Luxembourg (LU)

To:

Publication

Bulletin

1

Bulletin Heading:

SPC1

Bulletin edition number:

2018/01

Publication date:

15/01/2018

Description:

Section C : Published requests for Supplementary Protection Certificates – I1 publication

2

Bulletin Heading:

SPC2

Bulletin edition number:

2018/03

Publication date:

20/02/2018

Description:

Section D : Granted supplementary protection certificates – I2 publication

Annual Fees

Annual Fee Due Date:

30/06/2027

Annual Fee Number:

21

Annual Fee Amount:

410 Euro

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages
22/11/2017	General Document	21
23/01/2018	Certificate	1
23/01/2018	Publication	1
22/11/2017	Outgoing Correspondence	1
22/11/2017	General Document	3
22/11/2017	General Document	1
22/11/2017	Application Form	4